RHUMBLINE ADVISERS - ALDER BIOPHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$2,172,000
+70.6%
115,142
+6.5%
0.00%
+100.0%
Q2 2019$1,273,000
-13.5%
108,154
+0.3%
0.00%
-33.3%
Q1 2019$1,471,000
+46.8%
107,797
+10.3%
0.00%
+50.0%
Q4 2018$1,002,000
+9.2%
97,762
+77.3%
0.00%0.0%
Q3 2018$918,000
-11.4%
55,138
-15.9%
0.00%0.0%
Q2 2018$1,036,000
+29.5%
65,588
+4.1%
0.00%0.0%
Q1 2018$800,000
+13.6%
62,986
+2.5%
0.00%
+100.0%
Q4 2017$704,000
-19.5%
61,446
-13.9%
0.00%
-50.0%
Q3 2017$874,000
+24.3%
71,334
+16.1%
0.00%0.0%
Q2 2017$703,000
-40.3%
61,416
+8.5%
0.00%
-33.3%
Q1 2017$1,177,000
+4.3%
56,591
+4.3%
0.00%0.0%
Q4 2016$1,128,000
-33.4%
54,254
+5.0%
0.00%
-40.0%
Q3 2016$1,693,000
+54.0%
51,649
+17.3%
0.01%
+66.7%
Q2 2016$1,099,000
+86.3%
44,025
+82.9%
0.00%
+50.0%
Q1 2016$590,000
-24.1%
24,075
+2.3%
0.00%
-33.3%
Q4 2015$777,000
+15.5%
23,525
+14.5%
0.00%
+50.0%
Q3 2015$673,000
-28.0%
20,540
+16.3%
0.00%
-33.3%
Q2 2015$935,000
+251.5%
17,655
+91.4%
0.00%
+200.0%
Q1 2015$266,000
+29.8%
9,225
+30.9%
0.00%0.0%
Q4 2014$205,0007,0500.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Novo Holdings A/S 6,402,366$128,496,0006.43%
Cormorant Asset Management, LP 150,000$3,011,0000.80%
PFM Health Sciences, LP 738,027$14,812,0000.30%
Partner Investment Management, L.P. 27,893$560,0000.11%
Spark Investment Management LLC 32,100$642,0000.10%
PointState Capital LP 275,000$5,519,0000.07%
DRIEHAUS CAPITAL MANAGEMENT LLC 97,809$1,963,0000.06%
CADIAN CAPITAL MANAGEMENT, LP 100,000$2,007,0000.06%
Nicholas Investment Partners, LP 50,456$1,013,0000.06%
Baker Brothers Advisors 153,350$3,078,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders